Research aims to improve QOL by decreasing treatment toxicity
Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.
- Myeloma
- Research
Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.
Archer spent nine months, hundreds of kilometres from home and across state borders, undergoing life-saving blood cancer treatment during the COVID-19 pandemic.Â
To mark September’s Childhood Cancer Awareness Month, we’re sharing the inspiring stories of little warriors like Daisy, who was diagnosed with an aggressive blood cancer at just four months old.
Neda has experienced first-hand the benefit of Leukaemia Foundation support services - all thanks to the generosity of Australians.
Leukaemia Foundation Chairman, Dr Carrie Hillyard, has a special message for our supporters.
This Father’s Day, and every day, we’re celebrating brave Aussie dads like Bill Kuluris, who are living with a blood cancer.